<DOC>
	<DOCNO>NCT03069404</DOCNO>
	<brief_summary>The investigation multi-year observational study follow completion open-label , single dose Phase I/II study involve transplantation allogeneic HuCNS-SC cell 12 subject thoracic spinal cord injury . Subjects monitor routine interval safety preliminary efficacy 5 year post-transplantation Phase I/II investigation CL-N02-SC .</brief_summary>
	<brief_title>INSTrUCT-SCI : INdependent Observational STUdy Cell Transplantation SCI</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Must undergone HuCNSSC transplantation subject Phase I/II trial Must able provide write informed consent prior study related procedure Must agree comply good faith condition study attend require study visit Female subject pregnant remain eligible enrollment , MRI examination perform pregnancy . Female subject childbearing potential must negative urine pregnancy test prior MRI examination Subjects receive receive offprotocol immunosuppressive medication Subjects completion CLN02SC enter , enter interventional study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>